Diabetes Finals Flashcards
How often shoudl Hba1c be monitored in T1DM
What is the target in T1DM
HbA1c
should be monitored every 3-6 months
<48/6.5%
How many times a day to monitor blood glucose in T1DM
recommend testing at least 4 times a day, including before each meal and before bed
NOTE: do more frequent if pregnant, sick or breastfeeding and sport
Autoantibodies in T1DM
Anti-islet cell antibodies
Anti-GAD antibodies
Anti-insulin antibodies
Mx of Type1DM
Basal Bolus Regime
or Insulin pumps
Describe a Basal Bolus regime
SC
Basal - a long acting insulin once or twice daily:
Long-acting insulins in the background
insulin determir (Levemir): given once or twice daily
insulin glargine (Lantus): given once daily
Bolus
Short Acting/Rapid Insulin before meals
Actrapid (short)
Humulin S (S for short)
Rapid -
insulin aspart: NovoRapid
insulin lispro: Humalog
Disadvantages of an Insulin Pump
Advantages
Difficulties learning to use the pump
Having it attached at all times
Blockages in the infusion set
A small risk of infection
Good:
better blood sugar control, more flexibility with eating and less injections.
Dx of T2DM
If the patient is symptomatic:
fasting glucose greater than or equal to 7.0 mmol/l
random glucose greater than or equal to 11.1 mmol/l (or after 75g oral glucose tolerance test)
When HbA1c is used for the diagnosis of diabetes:
a HbA1c of greater than or equal to 48 mmol/mol (6.5%) is diagnostic of diabetes mellitus ( NOTE - cannot use this in children, CKD, gestational diabetes, HIV, anaemia, people taking steroids)
If not:
If the patient is asymptomatic the above criteria apply but must be demonstrated on **two **separate occasions.
Tx of Diabetic Neuropathy
Duloxetine
Features of Diabetic neuropathy
Sensory ‘glove and stocking’ loss
T2DM mx ladder
Lifestyle
Lifestyle + Metformin
Dual Therapy - Lifestyle+ Metformin and Another drug
ex:
metformin + DPP-4 inhibitor
metformin + pioglitazone
metformin + sulfonylurea
metformin + SGLT-2 inhibitor (if high heart disease present)
**Triple Therapy: **
Lifestyle, Metformin + 2 other drugs
ex:
metformin + DPP-4 inhibitor + sulfonylurea
metformin + pioglitazone + sulfonylurea
(Or can have SGLT2 as one of them if requirements met)
Or INSTEAD - Insulin Based treatment as third line
If none of this works, consider adding GLP-1 mimetic
* *If a triple therapy line has failed consider switiching one of the drugs to a GLP-1 mimetic, especially if BMI>35**
SGLT-2 inhibitor
Glycosuria (glucose in the urine)
Increased urine output and frequency
Genital and urinary tract infections (e.g., thrush)
Weight loss
Diabetic ketoacidosis
Pioglitazone SE
Weight gain
Heart failure - CI in heart stuff
Increased risk of bone fractures
A small increase in the risk of bladder cancer
DPP-4 inhibitors SE
Headaches
Low risk of acute pancreatitis
DPP-4 inhibitor mechanism
examples
DPP-4 inhibitors block the action of DPP-4, allowing increased incretin activity.
sitagliptin and alogliptin.
GLP-1 mimetics action
GLP-1 examples
GLP-1 mimetics imitate the action of GLP-1. Examples are exenatide and liraglutide.